{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:21:28Z","timestamp":1790601688350,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2018ZX10101001-005-003"],"award-info":[{"award-number":["2018ZX10101001-005-003"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFC0841500"],"award-info":[{"award-number":["2020YFC0841500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013279","name":"National Key New Drug Creation and Manufacturing Program, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["2019ZX09201005"],"award-info":[{"award-number":["2019ZX09201005"]}],"id":[{"id":"10.13039\/501100013279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.phymed.2022.154549","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T02:14:18Z","timestamp":1668824058000},"page":"154549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Huashibaidu formula attenuates sepsis-induced acute lung injury via suppressing cytokine storm: Implications for treatment of COVID-19"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5426-0324","authenticated-orcid":false,"given":"Fangbo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2022.154549_bib0001","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.4049\/jimmunol.1600940","article-title":"Gut microbial membership modulates CD4 T cell reconstitution and function after sepsis","volume":"197","author":"Cabrera-Perez","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.phymed.2022.154549_bib0002","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1586\/ers.10.71","article-title":"The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine","volume":"4","author":"Chen","year":"2010","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.phymed.2022.154549_bib0003","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","article-title":"Cytokine storm and sepsis disease pathogenesis","volume":"39","author":"Chousterman","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.phymed.2022.154549_bib0004","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.biopha.2017.09.094","article-title":"Lianqinjiedu decoction attenuates LPS-induced inflammation and acute lung injury in rats via TLR4\/NF-kappaB pathway","volume":"96","author":"Deng","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2022.154549_bib0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00210-015-1202-6","article-title":"Febuxostat protects rats against lipopolysaccharide-induced lung inflammation in a dose-dependent manner","volume":"389","author":"Fahmi","year":"2016","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154549_bib0006","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2022.154549_bib0007","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1471-4906(03)00139-X","article-title":"PI3K and negative regulation of TLR signaling","volume":"24","author":"Fukao","year":"2003","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.phymed.2022.154549_bib0008","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/jir.2019.0085","article-title":"Constitutive inflammatory cytokine storm: a major threat to human Health","volume":"40","author":"Gupta","year":"2020","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.phymed.2022.154549_bib0009","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/01.shk.0000090843.66556.74","article-title":"Lipopolysaccharide dose response in baboons","volume":"20","author":"Haudek","year":"2003","journal-title":"Shock"},{"key":"10.1016\/j.phymed.2022.154549_bib0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/bjh.15644","article-title":"Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy","volume":"183","author":"Hay","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.phymed.2022.154549_bib0011","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1248\/bpb.30.1617","article-title":"Role of phosphoinositide 3-kinase in innate immunity","volume":"30","author":"Hazeki","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phymed.2022.154549_bib0012","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41374-020-0404-9","article-title":"PI3K-Akt-mTOR\/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis","volume":"100","author":"Hu","year":"2020","journal-title":"Lab. Investig."},{"key":"10.1016\/j.phymed.2022.154549_bib0013","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.intimp.2015.10.027","article-title":"Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-kappaB pathway","volume":"29","author":"Jiang","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2022.154549_bib1014","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s11704-016-5485-7","article-title":"iGraph: an incremental data processing system for dynamic graph","volume":"10","author":"Ju","year":"2016","journal-title":"Front. Comput. Sci."},{"key":"10.1016\/j.phymed.2022.154549_bib0014","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-\u03b1 and IFN-\u03b3 Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2022.154549_bib0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4046\/trd.2016.79.2.53","article-title":"Sepsis and acute respiratory distress syndrome: recent update","volume":"79","author":"Kim","year":"2016","journal-title":"Tuberc. Respir. Dis. (Seoul)"},{"key":"10.1016\/j.phymed.2022.154549_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107087","article-title":"Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets","volume":"89","author":"Kumar","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2022.154549_bib0018","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","article-title":"SARS-CoV-2 and viral sepsis: observations and hypotheses","volume":"395","author":"Li","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2022.154549_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153671","article-title":"Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial","volume":"91","author":"Liu","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2022.154549_bib0020","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinasepathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2022.154549_bib0021","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3390\/md13021026","article-title":"Omega-3 fatty acid intervention suppresses lipopolysaccharide-induced inflammation and weight loss in mice","volume":"13","author":"Liu","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.phymed.2022.154549_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107773","article-title":"Intragastric and atomized administration of canagliflozin inhibit inflammatory cytokine storm in lipopolysaccharide-treated sepsis in mice: A potential COVID-19 treatment","volume":"96","author":"Niu","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2022.154549_bib0023","first-page":"129","article-title":"Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule","volume":"378","author":"Oldstone","year":"2014","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"10.1016\/j.phymed.2022.154549_bib0024","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000315915","article-title":"Endotoxins and other sepsis triggers","volume":"167","author":"Opal","year":"2010","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.phymed.2022.154549_bib0025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-291X(03)00837-4","article-title":"Gene expression of Toll-like receptors and associated molecules induced by inflammatory stimuli in the primary alveolar macrophage","volume":"305","author":"Oshikawa","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phymed.2022.154549_bib0026","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/biom11010091","article-title":"Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm","volume":"11","author":"Pum","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.phymed.2022.154549_bib0027","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41591-020-0752-4","article-title":"An immune-cell signature of bacterial sepsis","volume":"26","author":"Reyes","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2022.154549_bib0028","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1586\/eri.11.141","article-title":"Lung injury induced by sepsis: Lessons learned from large animal models and future directions for treatment","volume":"9","author":"Sadowitz","year":"2011","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.phymed.2022.154549_bib0029","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Sch\u00e4cke","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2022.154549_bib0030","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.phrs.2009.04.007","article-title":"Penehyclidine hydrochloride attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway","volume":"60","author":"Shen","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2022.154549_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153367","article-title":"Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trial","author":"Shi","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2022.154549_bib0032","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.phymed.2022.154549_bib0033","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2022.154549_bib0034","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMra1608077","article-title":"Acute respiratory distress syndrome","volume":"377","author":"Thompson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2022.154549_bib0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1073\/pnas.1118579109","article-title":"Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine\/threonine kinases PI3K\/Akt","volume":"109","author":"Troutman","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.phymed.2022.154549_bib0036","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.4161\/cc.21572","article-title":"Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K","volume":"11","author":"Troutman","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.phymed.2022.154549_bib0037","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tibs.2005.02.008","article-title":"Signalling by PI3K isoforms: insights from gene-targeted mice","volume":"30","author":"Vanhaesebroeck","year":"2005","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.phymed.2022.154549_bib0038","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1530\/EJE-07-0455","article-title":"Glucocorticoids and cardiovascular disease","volume":"157","author":"Walker","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.phymed.2022.154549_bib0039","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s10753-018-0824-5","article-title":"PI3K\/AKT and CD40L Signaling Regulate Platelet Activation and Endothelial Cell Damage in Sepsis","volume":"41","author":"Wan","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.phymed.2022.154549_bib0040","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.2147\/DDDT.S222296","article-title":"Paclitaxel alleviated sepsis-induced acute lung injury by activating MUC1 and suppressing TLR-4\/NF-\u03baB pathway","volume":"13","author":"Wang","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.phymed.2022.154549_bib0041","first-page":"473","article-title":"Chemical profiling of Huashi Baidu prescription, an effective anti-COVID-19 TCM formula, by UPLC-Q-TOF\/MS","volume":"19","author":"Wei","year":"2021","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.phymed.2022.154549_bib0042","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4049\/jimmunol.172.1.449","article-title":"Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis","volume":"172","author":"Williams","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.phymed.2022.154549_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.826535","article-title":"Exploration of the Specific Pathology of HXMM Tablet Against Retinal Injury Based on Drug Attack Model to Network Robustness","volume":"13","author":"Xi","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154549_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106749","article-title":"Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19","volume":"86","author":"Zhang","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2022.154549_bib0045","article-title":"Chinese Medicine Formula Huashibaidu Granule Early Treatment for Mild COVID-19 Patients: An Unblinded, Cluster-Randomized Clinical Trial","volume":"8","author":"Zhao","year":"2021","journal-title":"Front. Med. (Lausanne)"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711322006377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711322006377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:45:58Z","timestamp":1760553958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711322006377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":45,"alternative-id":["S0944711322006377"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2022.154549","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Huashibaidu formula attenuates sepsis-induced acute lung injury via suppressing cytokine storm: Implications for treatment of COVID-19","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2022.154549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"154549"}}